Dirk Sauer

1.1k total citations
18 papers, 901 citations indexed

About

Dirk Sauer is a scholar working on Cellular and Molecular Neuroscience, Neurology and Neurology. According to data from OpenAlex, Dirk Sauer has authored 18 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 8 papers in Neurology and 4 papers in Neurology. Recurrent topics in Dirk Sauer's work include Neuroscience and Neuropharmacology Research (8 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Dirk Sauer is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurological Disease Mechanisms and Treatments (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Dirk Sauer collaborates with scholars based in Switzerland, Germany and United States. Dirk Sauer's co-authors include Peter R. Allegrini, Katrin Rupalla, Christoph Wießner, Josef Krieglstein, Thomas Beck, Hans-Dieter Mennel, Gerhard Wilhelm Bielenberg, Graham E. Fagg, Jean Hubble and Peter A. LeWitt and has published in prestigious journals such as The Lancet Neurology, Journal of Cerebral Blood Flow & Metabolism and Life Sciences.

In The Last Decade

Dirk Sauer

18 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Sauer Switzerland 17 365 305 269 203 101 18 901
A. Sauter Switzerland 13 326 0.9× 357 1.2× 475 1.8× 101 0.5× 138 1.4× 17 1.2k
Yann Decker Germany 15 331 0.9× 215 0.7× 224 0.8× 172 0.8× 57 0.6× 18 856
Xueren Zhao United States 12 234 0.6× 358 1.2× 244 0.9× 215 1.1× 26 0.3× 15 931
Nina Vartiainen Finland 15 400 1.1× 437 1.4× 239 0.9× 208 1.0× 25 0.2× 16 1.0k
Pak H. Chan United States 12 259 0.7× 564 1.8× 404 1.5× 188 0.9× 32 0.3× 13 1.2k
Siesjø Bk Sweden 10 227 0.6× 271 0.9× 138 0.5× 106 0.5× 42 0.4× 14 685
Val R. Marcy United States 14 298 0.8× 423 1.4× 190 0.7× 220 1.1× 50 0.5× 18 940
José Melena United Kingdom 19 364 1.0× 1.1k 3.4× 394 1.5× 105 0.5× 215 2.1× 30 1.8k
Amy H. Moore United States 13 116 0.3× 226 0.7× 165 0.6× 193 1.0× 129 1.3× 15 838
B. J. Mršulja United States 9 374 1.0× 276 0.9× 273 1.0× 134 0.7× 45 0.4× 12 797

Countries citing papers authored by Dirk Sauer

Since Specialization
Citations

This map shows the geographic impact of Dirk Sauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Sauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Sauer more than expected).

Fields of papers citing papers by Dirk Sauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Sauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Sauer. The network helps show where Dirk Sauer may publish in the future.

Co-authorship network of co-authors of Dirk Sauer

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Sauer. A scholar is included among the top collaborators of Dirk Sauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Sauer. Dirk Sauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Olanow, C. Warren, Anthony H.V. Schapira, Peter A. LeWitt, et al.. (2006). TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet Neurology. 5(12). 1013–1020. 121 indexed citations
2.
Gershanik, Oscar S., Murat Emre, Gudrun Bernhard, & Dirk Sauer. (2003). Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(6). 963–971. 20 indexed citations
3.
Wießner, Christoph, Peter R. Allegrini, Katrin Rupalla, et al.. (1999). Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neuroscience Letters. 268(3). 119–122. 82 indexed citations
4.
Acklin, Pierre, Hans Allgeier, Yves P. Auberson, et al.. (1998). 5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(5). 493–498. 21 indexed citations
5.
Rupalla, Katrin, Peter R. Allegrini, Dirk Sauer, & Christoph Wießner. (1998). Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathologica. 96(2). 172–178. 135 indexed citations
6.
7.
Sauer, Dirk, et al.. (1995). The Competitive NMDA Antagonist CGP 40116 Permanently Reduces Brain Damage after Middle Cerebral Artery Occlusion in Rats. Journal of Cerebral Blood Flow & Metabolism. 15(4). 602–610. 21 indexed citations
8.
9.
10.
Allegrini, Peter R. & Dirk Sauer. (1992). Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis. Magnetic Resonance Imaging. 10(5). 773–778. 82 indexed citations
11.
Sauer, Dirk, et al.. (1992). Evaluation of quinolinic acid induced excitotoxic neurodegeneration in rat striatum by quantitative magnetic resonance imaging in vivo. Journal of Neuroscience Methods. 42(1-2). 69–74. 20 indexed citations
12.
Beck, Thomas, Andreas Wree, & Dirk Sauer. (1992). Chronic infusion of nerve growth factor does not rescue pyramidal cells after transient forebrain ischemia in the rat. Neuroscience Letters. 135(2). 252–254. 23 indexed citations
13.
Sauer, Dirk, et al.. (1990). PAF Antagonist Ginkgolide B Reduces Postischemic Neuronal Damage in Rat Brain Hippocampus. Journal of Cerebral Blood Flow & Metabolism. 10(1). 133–135. 100 indexed citations
14.
Krieglstein, Josef, et al.. (1989). Naftidrofuryl Protects Neurons against Ischemic Damage. European Neurology. 29(4). 224–228. 18 indexed citations
15.
Beck, Thomas, et al.. (1988). Effects of flunarizine on postischemic blood flow, energy metabolism and neuronal damage in the rat brain. European Journal of Pharmacology. 158(3). 271–274. 40 indexed citations
16.
Sauer, Dirk, et al.. (1988). Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow. Neuroscience Letters. 91(3). 327–332. 33 indexed citations
17.
Sauer, Dirk, et al.. (1988). Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sciences. 43(21). 1733–1739. 52 indexed citations
18.
Bielenberg, Gerhard Wilhelm, et al.. (1987). Effects of Cerebroprotective Agents on Cerebral Blood Flow and on Postischemic Energy Metabolism in the Rat Brain. Journal of Cerebral Blood Flow & Metabolism. 7(4). 480–488. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Sauter Breakdown of academic impact, for papers by Yann Decker Breakdown of academic impact, for papers by Xueren Zhao Breakdown of academic impact, for papers by Nina Vartiainen Breakdown of academic impact, for papers by Pak H. Chan Breakdown of academic impact, for papers by Siesjø Bk Breakdown of academic impact, for papers by Val R. Marcy Breakdown of academic impact, for papers by José Melena Breakdown of academic impact, for papers by Amy H. Moore Breakdown of academic impact, for papers by B. J. Mršulja
Rankless by CCL
2026